BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
175 hedge funds and large institutions have $4B invested in Blueprint Medicines in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 63 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1% more call options, than puts
Call options by funds: $16.4M | Put options by funds: $16.3M
0.15% more ownership
Funds ownership: 99.69% → 99.84% (+0.15%)
13% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 63
Holders
175
Holding in Top 10
12
Calls
$16.4M
Puts
$16.3M
Top Buyers
| 1 | +$32.1M | |
| 2 | +$27.4M | |
| 3 | +$19.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.9M |
| 5 |
BlackRock
New York
|
+$16.2M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$17.4M | |
| 3 | -$14.4M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$12.4M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$10.2M |